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Objective: To estimate excess health care expenditures associated with gastroesophageal
reflux disease (GERD) among elderly individuals with chronic obstructive pulmonary disease
(COPD) and examine the contribution of predisposing characteristics, enabling resources,
need variables, personal health care practices, and external environment factors to the excess
expenditures, using the Blinder−Oaxaca linear decomposition technique.
Methods: This study utilized a cross-sectional, retrospective study design, using data from
multiple years (2006−2009) of the Medicare Current Beneficiary Survey linked with feefor-service Medicare claims. Presence of COPD and GERD was identified using diagnoses
codes. Health care expenditures consisted of inpatient, outpatient, prescription drugs,
dental, medical provider, and other services. For the analysis, t-tests were used to examine
unadjusted subgroup differences in average health care expenditures by the presence of
GERD. Ordinary least squares regressions on log-transformed health care expenditures
were conducted to estimate the excess health care expenditures associated with GERD. The
Blinder−Oaxaca linear decomposition technique was used to determine the contribution
of predisposing characteristics, enabling resources, need variables, personal health care
practices, and external environment factors, to excess health care expenditures associated
with GERD.
Results: Among elderly Medicare beneficiaries with COPD, 29.3% had co-occurring GERD.
Elderly Medicare beneficiaries with COPD/GERD had 1.5 times higher ($36,793 vs $24,722
[P,0.001]) expenditures than did those with COPD/no GERD. Ordinary least squares regression revealed that individuals with COPD/GERD had 36.3% (P,0.001) higher expenditures
than did those with COPD/no GERD. Overall, 30.9% to 43.6% of the differences in average
health care expenditures were explained by differences in predisposing characteristics, enabling
resources, need variables, personal health care practices, and external environment factors
between the two groups. Need factors explained up to 41% of the differences in average health
care expenditures between the two groups.
Conclusion: Among elderly Medicare beneficiaries with COPD, the presence of GERD was
associated with higher expenditures. Need factors primarily contributed to the differences in
average health care expenditures, suggesting that the comanagement of chronic conditions may
reduce excess health care expenditures associated with GERD.
Keywords: Blinder−Oaxaca linear decomposition, geriatrics, comorbidities, respiratory disease,
esophageal disease
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Introduction
Chronic obstructive pulmonary disease (COPD), characterized by progressive and persistent airflow limitation,1−3 is
associated with high economic burden,4 with $29.5 billion
spent on direct costs annually.2 Prior research has documented that COPD exacerbations can be the key drivers of
health care expenditures5,6 accounting for approximately
70% of all direct costs.7,8 Often, co-occurring chronic conditions among individuals with COPD may be associated with
frequent COPD exacerbations.9
Specifically, gastroesophageal reflux disease (GERD), a
highly prevalent co-occurring condition among individuals
with COPD,10 can lead to frequent COPD exacerbations.11−15
A systematic review, with meta-analysis of randomized controlled trials and observational studies, found that the presence
of GERD is an independent and significant predictor of COPD
exacerbations15 and that individuals with COPD and GERD
had seven times the risk of experiencing COPD exacerbations
as compared with those with COPD but no GERD (relative risk
[RR] =7.57; 95% confidence interval [CI]: 3.84−14.94).15
Therefore, the presence of GERD can lead to higher
health care utilization and expenditures compared with those
with COPD and no GERD. Researchers, using the National
Health Insurance Database of Korea, have reported that
among nonelderly and elderly individuals, those with COPD
and GERD had an increased likelihood of hospitalizations
(adjusted odds ratio [OR] 1.54, 95% CI: 1.50−1.58) and
emergency room (ER) visits (OR 1.55, 95% CI: 1.48−1.62)
as compared with those with COPD but no GERD.16 However,
to date, no study has estimated the excess health care expenditures associated with GERD among elderly individuals with
COPD. It is important to conduct research among the elderly
as COPD prevalence rates are twice as high among elderly
individuals (.65 years) as compared with young adults
(45−64 years).17,18 In addition, multiple chronic conditions
are the norm rather than the exception among the elderly
individuals with COPD.19 Furthermore, it is important to
understand the factors associated with excess health care
expenditures among individuals with COPD and GERD so
as to develop clinical and programmatic interventions to
reduce health care expenditures.
Therefore, the primary objective of the study was to
estimate the excess health care expenditures associated with
GERD among elderly individuals with COPD and examine
the extent to which predisposing characteristics, enabling
resources, need variables, personal health care practices, and
external environment explain the excess expenditures associated with GERD among elderly individuals with COPD.
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Methods
Study design
This study adopted a cross-sectional study design with
retrospective observational data to examine excess health
care expenditures associated with GERD among elderly
individuals with COPD.

Data source
The data for this study were derived from the nationally
representative survey of Medicare beneficiaries, Medicare
Current Beneficiary Survey (MCBS). The MCBS is a continuous, multipurpose survey of a nationally representative
sample of aged, disabled, and noninstitutionalized Medicare beneficiaries.20 The MCBS consists of two modules:
1) “access to care” and 2) “cost and use.” For this study,
we used the cost and use module that contains information
regarding health care use, prescription drug use, and personal health care practices for all the Medicare beneficiaries.
Additionally, the MCBS provides detailed information on
expenditures and sources of payment for all services used by
Medicare beneficiaries, including copayments, deductibles,
and noninsured services.
To ensure adequate sample size, the current study pooled
cross-sectional annual releases of the cost and use files for the
years 2006–2009. As the years were pooled, the study sample
represents person-years rather than persons. However, we
use the term Medicare beneficiaries rather than person-year
for ease of presentation.

Analytical sample

Identification of elderly with chronic
obstructive pulmonary disease
Elderly Medicare beneficiaries aged .65 years with COPD
were identified using the International Classification of
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
codes for chronic bronchitis (491.xx) or emphysema (492.xx)
or unspecified chronic airway obstruction (496.xx). These
diagnosis codes have been utilized in published research to
identify individuals with COPD and to evaluate their health
outcomes.21−23 Use of one or more hospitalizations and one or
more outpatient encounters with COPD diagnosis has been
found to have a sensitivity of 85.0% (95% CI: 77.0−91.0)
and specificity of 78.4% (95% CI: 73.6−82.7).24 For the
current study, individuals with at least one inpatient visit or
two outpatient visits (14 days apart) with COPD codes were
considered to have diagnosed COPD.
Additional inclusion criteria were: community-dwelling,
fee-for-service Medicare benef iciaries with full-year
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e nrollment during the calendar year. Based on all the selection criteria the final sample consisted of 2,461 elderly
Medicare beneficiaries.

Dependent variable: total health care
expenditures
Total health care expenditures (hereafter referred to as health
care expenditures) were derived using sources of payment and
types of services. Health care expenditures were calculated by
adding the expenditures for inpatient, outpatient, prescription
drugs, dental, medical provider, and other services. Sources
of payment included third-party payers, such as Medicare,
Medicaid, Veterans Affairs Health Insurance, private health
maintenance organizations, employer-sponsored insurance
providers, individually purchased insurance providers, and
other payers.
To account for medical services inflation, expenditures
in 2006, 2007, and 2008 were converted to 2009-equivalent
dollars, using the annual consumer price index for medical
care services available from the Bureau of Labor Statistics.25
As expenditures data were skewed to the right, we transformed expenditures to a natural logarithmic scale, and used
log-transformed expenditures as the dependent variable in
the regression analyses.

Key independent variable: GERD (yes/no)
A binary indicator variable for the presence or absence of
GERD was used as the key independent variable. For the
ease of presentation, individuals with GERD are referred
as the “COPD/GERD” group and those without GERD are
referred as the “COPD/no GERD” group. Elderly Medicare
beneficiaries with GERD were identified using inpatient/
outpatient claims with ICD9 CM codes: 530.81 (esophageal
reflux, which includes gastroesophageal reflux) and 530.1x
(reflux esophagitis, which includes abscess of esophagus;
esophagitis due to a nitric oxide synthase, chemical, peptic,
postoperative, or regurgitant cause). These codes have been
used in prior research for identifying GERD from administrative claims data.26

Other independent variables
To identify the factors that contributed to the excess health
care expenditures associated with COPD/GERD, the
Anderson health care behavior/utilization model was used.27
Based on this model, independent variables were grouped
into: predisposing characteristics, enabling resources,
need variables, personal health care practices, and external
environment.

International Journal of COPD 2014:9
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Predisposing characteristics included sex (women or
men), age in years (65−69, 70−74, $75), and race/ethnicity
(White, African American, Latino, or “Other”). Enabling
resources included marital status (married or nonmarried),
education (less than high school, high school, more than high
school), poverty status (,200% of the federal poverty line
[FPL], 200%−400% of FPL, .400% of FPL), and Medicaid
coverage (yes or no). Need variables consisted of perceived
physical health status (excellent, very good, good, fair, or
poor), Charlson’s comorbidity index (CCI) score, and presence of mental health conditions (anxiety or depression).
Personal health care practices included body mass index
categories (underweight [0−18.5 kg/m2], normal [18.5−25.0
kg/m2], overweight [25.0−30.0 kg/m2], or obese [$30.0 kg/
m2]), and smoking status (current, past, never). External
environment was measured using metropolitan-dwelling
status (urban vs rural).

Statistical analysis
Unadjusted subgroup differences by the presence or absence
of GERD were tested using chi-square tests of independence.
As well, t-tests were used to examine statistically significant
differences in average health care expenditures among the
GERD and no GERD groups. To understand the association between GERD status and log-transformed health care
expenditures, multivariable ordinary least squares (OLS)
regressions were used. In these regressions, health care
expenditures was the dependent variable, and the independent variables were predisposing characteristics, enabling
resources, need variables, personal health care practices,
and external environment. For continuous variables, the
parameter estimates obtained from the OLS regressions were
exponentiated and interpreted as the percent change for each
unit change in the independent variable. For the categorical
variables, percent change in expenditure was calculated by the
formula exp(β)-1.28 All analyses were conducted using survey
procedures within statistical analysis system software (SAS
version 9.3; SAS Institute Inc., Cary, NC, USA).

Blinder−Oaxaca decomposition analyses
The Blinder−Oaxaca decomposition analyses, a wellaccepted regression-based technique, was used to explain
the extent to which predisposing characteristics, enabling
resources, need variables, personal health care practices, and
external environment contributed to differences in average
health care expenditures by GERD status.29,30 Using this
approach, the difference in average health care expenditures
between COPD/GERD and COPD/no GERD was divided
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into two parts: an explained and unexplained portion. The
explained portion, also referred to as “characteristics effect,”
represented differences in average expenditures due to differences in observed characteristics between the two groups
(GERD and no GERD). In other words, the explained portion
assessed how much of the differences in average expenditures
between “COPD/GERD” and “COPD/no GERD” could
be attributed to differences in predisposing characteristics,
enabling resources, need variables, personal health care practices, and external environment between the two groups.
The unexplained portion, also referred to as “coefficients
effect,” represented differences in average expenditures
that could not be explained, either because of differences in
unobserved or unmeasured characteristics between the two
groups (COPD/GERD and COPD/no GERD) or differences
in regression coefficient estimates between the two groups.
The explained portion was calculated by multiplying the
difference in average characteristics between the COPD/
GERD and COPD/no GERD groups with regression weights.
Alternative ways of estimating regression weights have been
proposed by Blinder and Oaxaca,29,30 Cotton,31 Neumark,32
Oaxaca and Ransom,33 and Reimers.34 In this study, the
explained portion was calculated by multiplying the differences in average characteristics between the COPD/GERD
and COPD/no GERD groups, using three different regression
weights as proposed by Blinder and Oaxaca, and Neumark:
1) coefficients of the characteristics from the regression
model using data of individuals with COPD/GERD (GERD
weights);29,30 2) coefficients of the characteristics from the
regression model using data of individuals with COPD/no
GERD (COPD weights); and 3) coefficients of the characteristics from the regression model using data from both COPD/
GERD and COPD/no GERD individuals (pooled weights).32
The pooled regression model did not include GERD status
as one of the independent variables in the regression model.
Therefore, the explained portion can vary depending on
whether GERD weights, COPD weights, or pooled weights
were used.

Results
In this study sample, 29.3% of the elderly Medicare beneficiaries with COPD had co-occurring GERD. The comparison
of beneficiary characteristics among individuals with COPD/
GERD and COPD/no GERD (presented in Table 1) did not
reveal any statistically significant differences in predisposing characteristics, enabling resources, personal health care
practices, or external environment. However, differences in

342

Powered by TCPDF (www.tcpdf.org)

submit your manuscript | www.dovepress.com

Dovepress

Table 1 Description of study sample characteristics by GERD
among elderly Medicare beneficiaries with COPD Medicare
Current Beneficiary Survey, 2006–2009

Total

GERD

No GERD

N

N

Wt%

Wt%

746 29.3

1,715 70.7

380 51.7
366 48.3

880
835

124 17.6
155 22.9
467 59.4

249
17.3
359
23.8
1,107 59.0

635
39
35
36

1,481
89
66
78

86.2
5.6
3.4
4.8

362 49.2
384 50.8

810
903

49.1
50.9

506 70.3
240 29.7

1,139 68.5
576
31.5

256 32.9
286 39.8
201 27.3

581
641
486

,200% FPL

450 59.3

1,008 57.3

200%-400% FPL

224 31.2

507

30.2

72

200

12.4

Sex
Female
Male
Age
65–69 years
70–74 years
$75 years
Race/ethnicity
White
 African American
 Latino
Other
Marital status
Married
 Not married
Metropolitan status
Urban
 Rural
Education
 Less than high school
 High school
 Above high school
Poverty status

$400% FPL
Medicaid status
Yes
 No
Perceived health
 Excellent/very good
 Good
Fair
Poor
Smoking status
Current smoker
Past smoker
 Never smoker
Body mass index
Underweight/normal
Overweight
Obese
Depression
Yes
 No
Anxiety
Yes
 No

85.7
5.4
4.1
4.7

9.5

P-value

52.0
48.0

32.5
37.8
29.7

160 20.9
586 79.1

308
17.0
1,407 83.0

137
246
226
130

432
613
441
215

***
18.5
33.6
30.5
17.5

25.3
36.4
26.1
12.2
*

121 16.7
479 65.3
141 18.0

359
22.5
1,050 61.1
297
16.4

268 35.7
272 36.9
198 27.3

700
591
414

166 22.0
580 78.0

208
12.3
1,507 87.7

124 16.2
622 83.8

151
9.0
1,564 91.0

40.4
33.9
25.7
***

***

(Continued)
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Table 1 (Continued)
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N

Wt%

No GERD
N

P-value

Wt%

Total

746 29.3

1,715 70.7

CCI categories
1
2
3
4
$5

90
122
163
106
265

342
371
315
246
441

***
12.4
17.2
21.7
14.7
34.0

20.7
21.9
18.2
14.4
25.0

Notes: Based on 2,461 elderly Medicare beneficiaries with COPD who were
observed between years 2006 and 2009. Asterisks represent significant association
between the presence of GERD and beneficiary characteristics, based on chi-square
tests. ***P,0.001; *0.01#P,0.05.
Abbreviations: CCI, Charlson’s Comorbidity Index; COPD, chronic obstructive
pulmonary disease; FPL, federal poverty line; GERD, gastroesophageal reflux disease;
Wt, weighted.

need variables were statistically significant between the two
groups. Elderly Medicare beneficiaries with COPD/GERD
had higher rates of poor perceived physical health (17.5% vs
12.2% [P,0.001]), depression (22% vs 12.3% [P,0.001]),
anxiety (16.2% vs 9.0% [P,0.001]), and CCI ($5) score
(34.0% vs 25.0% [P,0.001]) compared with those with
COPD/no GERD.
Among the elderly Medicare beneficiaries with COPD,
the average health care expenditure was $28,264. Table 2
presents the comparison of average health care expenditures among individuals with COPD/GERD and COPD/
no GERD. For ease of interpretation, we also calculated the
“ratio of means,” obtained by dividing the average health
care expenditures of the COPD/GERD group by the average health care expenditures of the COPD/no GERD group.
Among all elderly Medicare beneficiaries, those with COPD/
GERD had 1.5 times higher ($36,793 vs $24,722 [P,0.001])
expenditures than did beneficiaries with COPD/no GERD.
Statistically significant differences in average health care
expenditures among the COPD/GERD and COPD/no
GERD groups were obtained for each of the beneficiary
characteristics. The average health care expenditures for
COPD/GERD group were significantly greater for all groups
except the Whites, African Americans, Latinos, and those
with income greater than 400% FPL. The ratio of means
ranged from as high as 1.69 (CCI =1) to as low as 1.12
(poverty status 400% FPL).
Table 3 summarizes the results from separate OLS
regression models on average log-transformed health care
expenditures among the COPD/GERD and COPD/no
GERD groups. The bottom panel of the table also presents
the intercept, parameter estimate and significance of the
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Table 2 Description of average annual health care expenditures
by GERD among elderly Medicare beneficiaries with COPD
Medicare Current Beneficiary Survey, 2006–2009
GERD

No GERD

Ratio of
means

P-value

$36,793

$24,722

1.49

***

$35,446
$37,261

$23,674
$25,877

1.50
1.44

***
***

$35,622
$32,950
$37,880

$23,928
$22,834
$25,740

1.49
1.44
1.47

**
**
***

$43,343
$52,436
$36,816
$35,061

$31,964
$33,640
$25,970
$23,864

1.36
1.56
1.42
1.47

***

$33,393
$39,203

$23,591
$25,852

1.42
1.52

***
***

$36,397
$36,177

$25,539
$23,000

1.43
1.57

***
***

$35,494
$33,810
$40,068

$25,191
$24,045
$25,136

1.41
1.41
1.59

***
***
***

,200% FPL

$32,336

$22,623

1.43

***

200%-400% FPL

$39,133

$24,979

1.57

***

$32,311

$28,943

1.12

$41,840
$34,901

$28,831
$23,915

1.45
1.46

***
***

$24,987
$37,621
$33,472
$52,000

$16,040
$30,303
$22,189
$38,713

1.56
1.24
1.51
1.34

***
**
***
**

$30,634
$35,277
$38,069

$19,260
$25,277
$26,611

1.59
1.40
1.43

***
*
***

$38,908
$34,281
$36,486

$25,449
$23,113
$25,652

1.53
1.48
1.42

***
***
***

$44,790
$33,931

$35,850
$23,163

1.25
1.46

*
***

$38,223
$35,964

$30,898
$24,139

1.24
1.49

*
***

All
Sex
Female
Male
Age
65–69 years
70–74 years
$75 years
Race/ethnicity
White
 African American
 Latino
Other
Marital status
Married
 Not married
Metropolitan status
Urban
 Rural
Education
 Less than high school
 High school
 Above high school
Poverty status

$400% FPL
Medicaid status
Yes
 No
Perceived health
 Excellent/very good
 Good
Fair
Poor
Smoking status
Current smoker
Past smoker
 Never smoker
Body mass index
Underweight/normal
Overweight
Obese
Depression
Yes
 No
Total
Anxiety
Yes
 No

(Continued)

submit your manuscript | www.dovepress.com

Dovepress

Powered by TCPDF (www.tcpdf.org)

343

Dovepress

Ajmera et al

International Journal of Chronic Obstructive Pulmonary Disease downloaded from https://www.dovepress.com/ by 50.121.219.110 on 12-Jun-2020
For personal use only.

Table 2 (Continued)

CCI categories
1
2
3
4
$5

No GERD

Ratio of
means

P-value

$18,252
$20,769
$28,243
$41,259
$54,362

$10,813
$15,534
$22,044
$27,749
$44,726

1.69
1.34
1.28
1.49
1.22

***
**
**
***
**

Notes: Based on 2,461 elderly Medicare beneficiaries with COPD who were
observed between years 2006 and 2009. Asterisks represent significant subgroup
difference in total annual health care expenditures, by beneficiary characteristics
among those with and without GERD, based on t-tests. ***P,0.001; **0.001#P,0.01;
*0.01#P,0.05.
Abbreviations: CCI, Charlson’s Comorbidity Index; COPD, chronic obstructive
pulmonary disease; FPL, federal poverty line; GERD, gastroesophageal reflux disease;
Wt, weighted.

COPD/GERD indicator variable, which was obtained from
a pooled OLS regression on average log-transformed health
care expenditures. As seen from the bottom panel, the presence of GERD was associated with greater expenditures.
Elderly Medicare beneficiaries with COPD/GERD had 36.3%
exp(β) - 1 (P,0.001) higher expenditures than did those with
COPD/no GERD.

Blinder–Oaxaca linear
decomposition analysis
The results from the postregression Blinder–Oaxaca linear
decomposition analysis are summarized in Table 4. The
average log-transformed health care expenditure for the
COPD/GERD group was 10.165 units; the corresponding
figure for COPD/no GERD was 9.651 units. This represented
a difference of 0.514 units in average log-transformed health
care expenditures. Using GERD weights, of this difference,
it was found that differences in predisposing characteristics, enabling resources, need variables, personal health
care practices, and external environment only explained
0.16 units. This represented 30.95% of the differences in
average log-transformed health care expenditures. Using
pooled weights, a 0.22-unit difference was explained by differences in beneficiary characteristics. Thus, the explained
portion represented (0.22/0.51) 42.39% of the differences in
average log-transformed health care expenditures between
the two groups. When COPD weights were used, 0.29 units
were due to differences in beneficiary characteristics between
the two groups. This represented 43.56% of the differences
in average log-transformed health care expenditures.
Further examination of the decomposition results
revealed that differences in CCI score explained 22.2% of
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the differences in average log transformed health care expenditures between the two groups using pooled weights. This
can be interpreted as follows: keeping all the factors same, if
COPD/GERD group had a similar distribution of CCI score
as compared to those with COPD/no GERD, the average
log-transformed health care expenditures would decrease by
0.114 units. The presence of depression and/or anxiety contributed 0.05 units (9.7%) to the explained portion. If COPD/
GERD group had similar rates of depression and/or anxiety
as the COPD/no GERD group, the difference in average logtransformed expenditures would be reduced by 0.05 units.
Predisposing characteristics, enabling resources, personal
health practices and external environment contributed to a
very small portion (2.5%) of explained portion of the differences in average log-transformed health care expenditures.
Similar findings were observed when COPD weights and
GERD weights were used. When GERD weights were used,
the CCI score contributed to 17.5% of the explained portion
of the difference in average log-transformed health care
expenditures; whereas, when COPD weights were used, the
CCI score contributed to 23.6% of the explained portion of
difference in log-transformed average expenditures between
the two groups.

Discussion
This study examined the excess health care expenditures
associated with GERD among elderly Medicare beneficiaries
with COPD, using a nationally representative survey linked
to Medicare fee-for-service claims. In this study, the overall
prevalence of GERD was 29.3%. Although no study has specifically examined the prevalence of GERD in elderly individuals with COPD, our estimates are somewhat consistent with
those reported in a review (ranging from 30% to 60%) of the
literature on extrapulmonary comorbidities in COPD.10
Even after controlling for predisposing characteristics,
enabling resources, need variables, personal health care
practices, and external environment, the presence of GERD
was associated with 36% higher (P,0.001) health care
expenditures. The excess expenditures associated with GERD
status can be due to several factors. Previous studies have
suggested that the presence of GERD among individuals with
COPD aggravated respiratory infections35 and increased the
risk of COPD-related exacerbations,12,15,16,36 which may lead to
higher health care expenditures. Conversely, common COPD
manifestations, such as lung hyperinflation, can also complicate GERD symptoms,37,38 leading to higher expenditures The
presence of GERD may also increase other complications,
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Table 3 Factors associated with total health care expenditures: results from ordinary least squares regression on logged expenditures
Medicare Current Beneficiary Survey, 2006–2009
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No GERD
Intercept
Sex
Female
Male
Age
65–69 years
70–74 years
$75 years
Race
 African American
 Latino
Other
White
Marital status
Married
 Not married
Metropolitan status
Urban
 Rural
Education
 Less than high school
 High school
 Above high school
Poverty status
,200% FPL
200%–400% FPL

GERD

Beta

SE

P

Beta

SE

P

Beta

SE

P

9.960

0.213

***

9.569

0.163

***

9.663

0.152

***

0.026

0.065

-0.035

0.058

-0.027

0.045

-0.030
-0.110

0.102
0.084

-0.029
-0.031

0.072
0.061

-0.035
-0.049

0.066
0.055

-0.038
0.077
-0.193

0.143
0.172
0.119

0.066
0.102
-0.036

0.119
0.118
0.102

0.020
0.087
-0.109

0.088
0.096
0.083

-0.121

0.073

-0.125

0.045

-0.115

0.036

-0.039

0.059

0.039

0.059

0.027

0.048

-0.065
-0.142

0.094
0.097

-0.101
-0.095

0.058
0.056

-0.097
-0.112

0.054
0.054

0.001

0.088
0.093

-0.208
-0.149

0.093
0.078

-0.148
-0.123

0.074
0.067

0.075

0.060

0.061

0.045

-0.550
-0.366
-0.141

0.074
0.061
0.064

***
***
*

-0.562
-0.347
-0.149

0.064
0.058
0.050

***
***
**

-0.215
0.057

0.074
0.060

**

-0.226
0.053

0.069
0.050

**

-0.045
-0.088

0.071
0.050

-0.027
-0.068

0.058
0.042

0.276

0.061

***

0.324

0.052

***

0.325

0.077

***

0.251

0.051

***

0.198

0.011

***

0.186

0.008

***

-0.070

$400% FPL
Medicaid coverage
Medicaid
0.092
-0.041
 No Medicaid
Health status
 Excellent/very good
0.110
-0.539
 Good
0.092
-0.256
Fair
0.074
-0.187
Poor
Smoking status
Current smoker
0.106
-0.119
Past smoker
0.067
0.085
 Never smoked
Body mass index
Underweight/normal
0.020
0.076
Overweight
0.074
-0.056
Obese
Depression
Yes
0.310
0.069
 No
Anxiety
Yes
0.010
0.074
 No
CCI
0.147
0.012
Pooled regression coefficient for presence of GERD
Intercept

Pooled§

9.594

0.148

***
**
*

***

***

**

*

**

*

*

***

(Continued)
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Table 3 (Continued)
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No GERD
GERD
Yes
 No

GERD

Beta

SE

P

0.310

0.037

***

Beta

Pooled§
SE

Beta

P

SE

P

Notes: Based on 2,461 elderly Medicare beneficiaries with COPD who were observed between years 2006 and 2009. Asterisks represent significant group differences in logtransformed total health care expenditures, based on ordinary least squares regression models. Blank rows represent the reference groups. §Pooled regression coefficients
are obtained from the regression model without GERD status as one of the independent variables. ***P,0.001; **0.001#P,0.01; *0.01#P,0.05.
Abbreviations: CCI, Charlson’s Comorbidity Index; COPD, chronic obstructive pulmonary disease; FPL, federal poverty line; GERD, gastroesophageal reflux disease;
SE, standard error; Wt, weighted.

such as chest pain, chronic cough, and sinusitis,39 that may
increase overall health care expenditures.
The current study also used the unique Blinder–Oaxaca
linear decomposition technique, to examine the extent
to which the differences in predisposing characteristics,
enabling resources, need variables, personal health care
practices, and external environment explained the difference
in average health care expenditures between the two groups
(COPD/GERD and COPD/no GERD). Need variables (CCI,
perceived health status, anxiety, and depression) primarily
explained the difference in average log-transformed health
care expenditures between the two groups. The findings from
this study highlight the role of comanagement of chronic
conditions among elderly individuals with COPD. Multimorbidity, defined by the presence of two or more coexisting chronic conditions, is a major challenge among elderly
individuals.40,41 In this context, our study strengthens the need
for developing clinical practice guidelines for comanagement of multiple chronic conditions. Additionally, the findings from this study highlight the importance of emerging
health care delivery models, such as “medical homes,” in
reducing health care expenditures. These models emphasize
care-coordination for management of the elderly Medicare

beneficiaries with multiple chronic conditions, to improve
outcomes. In addition, the recently introduced chronic care
management and fiscal incentives for providing care to elderly
with multiple chronic conditions may lead to reduced health
care expenditures.42
A noteworthy finding of our study is that more than 50%
of the difference in average log-transformed health care
expenditures between the two groups remained unexplained.
It is plausible that some portion of this difference could be due
to unmeasured factors related to COPD and GERD, such as
medication adherence, severity of COPD, severity of GERD,
symptomatology, health beliefs, and propensity to seek care.
Therefore, future research needs to evaluate the contributions
of such factors in assessing excess health care expenditures
among elderly individuals with COPD and GERD.
Our study has many advantages and some limitations.
The advantages include the use of a nationally representative survey of elderly Medicare beneficiaries linked to their
fee-for-service claims data, the clinical diagnosis of COPD
and GERD using validated ICD-9-CM codes,24,43 the large
sample size, and the comprehensive set of independent factors
that can influence health care expenditures. It could be suggested that the identification of individuals with COPD using

Table 4 Factors explaining excess health care expenditures with presence of GERD among elderly Medicare beneficiaries having
COPD (Blinder-Oaxaca linear decomposition analysis) Medicare Current Beneficiary Survey, 2006–2009
Total difference explained (log units)
Predisposing characteristics (age, race, sex)
Enabling resources (education, marital status,
Medicaid coverage, metropolitan status, poverty status)
External environment (metropolitan status)
Physical health need variables (CCI, health status)
Mental health need variables (anxiety, depression)
Personal health care practices (BMI, smoking status)
Total difference explained

GERD weights

COPD weights

Pooled weights

0.159
0.31%
-1.06%

0.290
0.18%
-1.00%

0.216
0.22%
-0.54%

-0.14%
24.47%
5.99%
1.38%
30.95%

0.14%
31.69%
9.76%
2.79%
43.56%

0.00%
30.24%
9.64%
2.83%
42.39%

Notes: Based on 2,461 elderly Medicare beneficiaries with COPD, who were observed between years 2006 and 2009. For the ease of representation, the percent differences
are explained for the group of characteristics. (These groups are derived from the Andersen’s health care behavior model). Lnexp (COPD/GERD) = predicted average logtransformed total health care expenditures for the COPD/GERD group; lnexp (COPD/no GERD) = predicted average log-transformed total health care expenditures for
COPD/no GERD group; lnexp (COPD/GERD) =10.165; lnexp (COPD/no GERD) =9.651; lnexp (COPD/GERD) - lnexp (COPD/no GERD) =0.514.
Abbreviations: BMI, body mass index; CCI, Charlson’s Comorbidity Index; COPD, chronic obstructive pulmonary disease; GERD, gastroesophageal reflux disease.
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ICD-9-CM diagnoses codes may not be the most accurate
method; however, the ICD-9-CM codes used in this study have
been previously validated and also utilized in several prior
studies.24 This study also used a unique Blinder−Oaxaca
linear decomposition technique to identify the factors that
contribute to excess health care expenditures.29,30 A limitation of this study was the lack of information on the severity
and duration of COPD and GERD. However, the current
study adjusted for perceived health status, which would
serve as a proxy for overall disease severity. Also, although
the decomposition technique is important in quantifying
the contribution of each factor in explaining the difference
in average health care expenditures, it cannot point to the
underlying mechanisms behind the differences in health care
expenditures. In addition, the findings from this study can
only be generalizable to community-dwelling, fee-for-service
Medicare enrollees.

Conclusion
In conclusion, this is the first study to assess excess health
care expenditures associated with GERD among elderly
individuals with COPD, using a nationally representative survey linked to Medicare fee-for-service claims.
Individuals with co-occurring COPD/GERD had significantly higher total health care expenditures than did those
with COPD/no GERD, even after controlling for a comprehensive set of independent variables. Blinder−Oaxaca
linear decomposition revealed that the CCI score, perceived
health status, anxiety, and depression explained the major
portion of the differences in average total health care expenditures between the two groups. This finding suggests that
comprehensive and coordinated health care management
of individuals with co-occurring COPD and GERD may
be necessary, to reduce excess health care expenditures
associated with GERD.
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